Efecto antidepresivo de la Ketamina intranasal en el cuidado paliativo de pacientes con cáncer terminal
Archivos de Medicina September 4, 2023 Secundino González Pardo, Lourdes González-Longoria Boada, Francisco Javier Lopez-Munoz
Background: patients with cancer are more likely to have affective disorders. Antide-pressant treatments take weeks to work. Evidence suggests that ketamine delivered by any route treats these symptoms, making it a recommendable option for oncologic patients what are they presenting depression, anxiety, and suicidal ideation. Material and methods: a randomized, double-blind, placebo-controlled...